UPDATE 1-Lilly to buy cancer drug developer AurKa Pharma
May 14, 2018 at 08:14 AM EDT
May 14 (Reuters) - Eli Lilly and Co will buy AurKa Pharma Inc in a deal potentially worth up to $575 million, the U.S. drugmaker said on Monday, seeking access to the privately-held firm's experimental cancer treatment for solid tumors.
